Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ ;vc lAsJ
LEngZ~sV/
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© D^s0EW-
E
q AVfbcb
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© Bb[0\Hs7
b)hOzx
1.Co-stimulators (or co-stimulating molecules) txfw
Lqx
mERZ_[a2
2.NK-kB y5Wqu9C\Io
3Ra\2(bR
3.Immunoglobulin superfamily wz0$g4
ioY\8i
4.antigen-presenting cell (APC) ;*4tVp,
dI
ZTLb"a
5.death domain .xz,pn}
X|damI%
6.CCR and CXCR P$6f +{
.f !]
@"\
7.Lectin (or mitogen) BtpjQNN
Vi?
~0.Z%
8.Clusters of differentiation, CD) p[@oF5M
QK3j_'F=E
9.B7 family sPE)m_u
bDZKQ&
10.Cytotoxic T lymphocyte, CTL) @1/}-.(n
]EVe@
11.IL-15 and IL-15 receptor (IL-15R) S QM(8*:X
N+C)/EN$
12.MHC restriction SZK)q
v`_i1h9p{
13.Affinity-chromatography l)i&ATvCE
*_{
l
14.Cyctosprin A, CsA 0?6If+AC
lC /Hib
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) e\^g|60f_
_d\u!giy
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© (?!(0Ywbg
;e~{TkD
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 %0+h
_>gXNS r4u
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ z<yNG/M1>U
aDN6MZM
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ KJ0xp hf
:Wyn+
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© Xr@l+zr
( Lok
ÃâÒßѧרҵ£º .])>A')r
KMxNH,5
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ 3~[`[4n^
`G=ztL!gq
Ïû»¯ÄÚ¿Æ£º S3ab0JM
qYgwyj=4
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ RLYU\@kK?
dWsT Jyx~
ѪҺ²¡Ñ§×¨Òµ£º |eH wp
]&Y#)ebs
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿